GTBP News and Press, GT Biopharma Inc. From 05/20/21

These Current & Former Penny Stocks Are Making Their Mark In 2021 Penny stocks have been a big focus for retail traders over the last few years. In fact, if you look at any of the top small-cap stock ETFs, the trend is clear right now. Since the depths of the pandemic drop, the Russ...

Are Analysts Right About These Penny Stocks? Penny stocks are well-known for their volatile nature. The definition of these cheap shares refers to those trading under $5. So even a 50 cent move can be a meaningful gain or loss. For this reason, traders have flocked in droves to find the...

GT Biopharma to Host Interim GTB-3550 TriKE™ Data Review Call with Dr. Jeffrey S. Miller on May 19, 2021 at 4:00 PM ET PR Newswire BEVERLY Hills, Calif. , May 18, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP) a clinical stage biopharmaceutical com...

GT Biopharma (GTBP): Q1 GAAP EPS of -$1.83.Cash, cash equivalents and investments were $27.6M.Press Release For further details see: GT Biopharma reports Q1 results

GT Biopharma Reports First Quarter 2021 Results Announced Encouraging Interim Results Demonstrating a 63.7% Reduction in Bone Marrow Blast Levels from its GTB-3550 TriKE™ Phase I/II clinical trial for the Treatment of MDS and AML Announced Revised Design of the GTB-35...

Hot Penny Stocks To Watch You Might’ve Missed This Year Most people think of penny stocks as fly-by-night companies that see explosive moves and then fade off into the sunset of a massive sell-off. While that may be true for some of these cheap stocks, it isn’t true for al...

GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™ Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product Candidates PR Newswire BEVERLY HILLS, Calif. , May 12, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: G...

Have you seen these former penny stocks? When you hear about penny stocks, what comes to mind? Based on the formal definition, we’re talking about cheap stocks trading under $5. But don’t get things confused. Just because we’re talking about lower-priced equities, i...

Gainers: Stealth BioTherapeutics (MITO) +45%, Biofrontera (BFRA) +18%, BioCryst Pharmaceuticals (BCRX) +15%, Orgenesis (ORGS) +12%, GT Biopharma (GTBP) +4%.Losers: Regional Health Properties (RHE) -24%, VYNE Therapeutics (VYNE) ...

Are You Watching These Former Penny Stocks Right Now? Penny stocks are well-known for their high level of risk and reward. While it’s relatively normal to see stocks under $5 jump sporadically, it’s less frequent to see cheap stocks go on to “graduate” from t...